Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study

International Journal of Cardiology

Volumn 146, Issue 3, 2011, Pages 404-407

  Ashton, Emma ^a   Windebank, Emma ^c   Skiba, Marina ^b   Reid, Christopher ^b   Schneider, Hans ^c   Rosenfeldt, Franklin ^c   Tonkin, Andrew ^b   Krum, Henry ^b,c  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

CHF; Coenzyme Q10; Collagen; Statin

Indexed keywords

COLLAGEN; PLACEBO; PROCOLLAGEN; PROCOLLAGEN PINP; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; ROSUVASTATIN; UBIDECARENONE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TURNOVER TIME;

CHRONIC DISEASE; FEMALE; FLUOROBENZENES; HEART FAILURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRIMIDINES; SULFONAMIDES; VENTRICULAR REMODELING;

EID: 78951482018     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.12.028     Document Type: Article

References (24)

1. J.J. McMurray, and M.A. Pfeffer Heart failure Lancet 365 2005 1877 1889
2. H. Krum, and J.J. McMurray Statins and chronic heart failure: do we need a large-scale outcome trial? J Am Coll Cardiol 39 2002 1567 1573
3. P. van der Harst, A.A. Voors, W.H. van Gilst, M. Bohm, and D.J. van Veldhuisen Statins in the treatment of chronic heart failure: a systematic review PLoS Med 3 8 2006 e333
4. J. Kjekshus, P. Dunselman, and M. Blideskog A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics Eur J Heart Fail 7 2005 1059 1069
5. L. Tavazzi, G. Tognoni, and M.G. Franzosi Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure Eur J Heart Fail 6 2004 635 641
6. H. Krum, R. Latini, and A.P. Maggioni Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT Int J Cardiol 119 1 2007 48 53
7. H. Krum, E. Ashton, and C. Reid Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure J Card Fail 13 1 2007 1 7
8. K. Node, M. Fujita, Kitakaze, M. Hori, and J. Liao Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy Circulation 108 2003
9. S. Sola, Muhammad Q.S. Mir, S. Lerakis, N. Tandon, and B. Khan Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure J Am Coll Cardiol 47 2006 332 337
10. A. Hadj, S. Pepe, and F. Rosenfeldt The clinical application of metabolic therapy for cardiovascular disease Heart Lung Circ 16 2007 S56 S64
11. G.P. Littarru, and P. Langsjoen Coenzyme Q10 and statins: biochemical and clinical implications Mitochondrion 7 2007 S168 S174 Suppl
12. F. Zannad, F. Alla, B. Dousset, A. Perez, and B. Pitt Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES) Rales Investig Circ 102 2000 2700 2706
13. B. López, A. González, N. Varo, C. Laviades, R. Querejeta, and J. Díez Biochemical assessment of myocardial fibrosis in hypertensive heart disease Hypertension 38 2001 1222 1226
14. J. Martin, R. Denver, M. Bailey, and H. Krum In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodeling Clin Exp Pharmacol Physiol 32 9 2005 697 701
15. S. Hayashidani, H. Tsutsui, and T. Shiomi Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction Circulation 105 2002 868 873
16. F. Rosenfeldt, S. Marasco, and W. Lyon Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue J Thorac Cardiovasc Surg 129 2005 25 32
17. J. Melkko, S. Kauppila, and S. Niemi Immunoassay for intact amino-terminal propeptide of human type I procollagen Clin Chem 42 1996 947 954
18. S.L. Molyneux, C.M. Florkowski, and P.M. George Coenzyme Q10: an independent predictor of mortality in chronic heart failure J Am Coll Cardiol 52 18 2008 1435 1441
19. C.H. Strey, J.M. Young, and S.L. Molyneux Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure Atherosclerosis 179 1 2005 201 206
20. B.S. Burlew, and K.T. Weber Connective tissue and the heart. Functional significance and regulatory mechanisms Cardiol Clin 18 2000 435 442
21. S.A. Chang, Y.J. Kim, and H.W. Lee Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy Hypertension 54 3 2009 591 597
22. P.H. Langsjoen, and A.M. Langsjoen Supplemental ubiquinol in patients with advanced congestive heart failure Biofactors 2008 119 128
23. M. Berman, A. Erman, and T. Ben-Gal Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study Clin Cardiol 27 5 2004 295 299
24. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150